Maintaining a Sustainable Environment for Innovation: Ending the Evidence Arms Race for Regulatory and Reimbursement Decision-Making
This article was originally published in RPM Report
Executive Summary
Increasing attention on containing healthcare costs has spurred new business opportunities in data aggregation, real-time analytics, and rapid translation of data into evidence on the value of new innovation. This has become a race for more and faster evidence. But is the investment made by manufacturers, payers, and the government resulting in better evidence to aid patients and clinicians in making better decisions?